Predicting Immunotherapy Outcomes in Glioblastoma Patients through Machine Learning.

Simple Summary: This scientific study focuses on glioblastoma, a highly aggressive cancer with a poor prognosis. Despite various treatment modalities, including immune checkpoint inhibitors (ICBs), the efficacy of ICBs remains limited, prompting the need for a proactive approach to understand treatm...

Full description

Bibliographic Details
Published in:Cancers Vol. 16; no. 2; pp. 408 - 421
Main Author: Mestrallet, Guillaume
Format: pictorial research tables/charts Journal Article
Published: MDPI Jan2024
Online Access:View this record in EBSCOhost